Series C - Neos Therapeutics
Investment Firm
Overview
Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.
Announced Date
Mar 04, 2014
Funding Type
Series C
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
 CMEA Capital |
 Burrill & Company |
Round Details and Background
Neos Therapeutics raised $15500000 on 2014-03-04 in Series C
Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.
Company Funding History
9
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 23, 2014 |  Series C - Neos Therapeutics | - | 2.5M | |
| Mar 04, 2014 | Series C - Neos Therapeutics | 4 | - | 15.5M |
| Jun 09, 2011 | Series B - Neos Therapeutics | - | 13.6M | |
| Nov 24, 2009 | Series B - Neos Therapeutics | - | 29.0M |
Recent Activity
There is no recent news or activity for this profile.